Skip to content

Total debt at other companies

Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$8.38M-11.8%
Pfizer logo
PfizerPFE
Philip Morris International logo
Philip Morris InternationalPM

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's total debt?
Achieve Life Sciences (ACHV) reported total debt of $5.63M in Q1 2026.
How has Achieve Life Sciences's total debt changed year-over-year?
Achieve Life Sciences's total debt increased by 332.1% year-over-year, from $1.3M to $5.63M.
What is the long-term trend for Achieve Life Sciences's total debt?
Over 5 years (2020 to 2025), Achieve Life Sciences's total debt has grown at a 86.1% compound annual growth rate (CAGR), from $169K to $3.77M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.